Nonmyelin-specific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 170, Issue 2, 2003, Pages 831-837

  Jones, Richard E ^a   Kay, Thomas ^a   Keller, Thomas ^a   Bourdette, Dennis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CELL TRANSFER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037438487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.2.831     Document Type: Article

References (31)

1. Noseworthy, J. H., C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker. 2001. Multiple sclerosis. N. Engl. J. Med. 343:938.
2. Cohen, J. A., D. M. Essayan, B. Zweiman, and R. P. Lisak. 1987. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 108: 203.
3. Whitham, R. H., D. N. Bourdette, G. A. Hashim, R. M. Herndon, R. C. Ilg, A. A. Vandenbark, and H. Offner. 1991. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immmol. 146:101.
4. Lannes-Vieira, J., J. Gehrmann, G. W. Kreutzberg, and H. Wekerle. 1994. The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates. Acta Neuropathol. 87:435.
5. Smeltz, R. B., and R. H. Swanborg. 1998. Concordance and contradiction concerning cytokines and chemokines in experimental demyelinating disease. J. Neurosci. Res. 51:147.
6. Voskuhl, R. R., R. Martin, C. Bergman, M. Dalai, and N. H. Ruddle. 1993. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137.
7. Stinissen, P., and J. Raus. 1999, Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Acta Neurol. 99:65.
8. Tokuchi, F., M. Nishizawa, J. Nihei, K. Motoyama, K. Nagashima, and T. Tabira. 1990. Lymphokine production by encephalitogenic and non-encephalitogenic T-cell clones reactive to the same antigenic determinant. J. Neuroimmunol. 30:71.
9. Beraud, E., C. Balzano, A. J. Zamora, S. Varriale, D. Bernard, and A. Ben-Nun. 1993. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. J. Neuroimmunol. 47:41.
10. Ramirez, F., and D. Mason. 2001. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Eur. J. Immunol. 30:747.
11. Pette, M., K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale, G. Giederich, A. Hinkkanen, J. T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968.
12. Chou, Y. K., D. N. Bourdette, H. Offner, R. Whitham, R. Y. Wang, G. A. Hashim, and A. A. Vandenbark. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 39:105.
13. Hemmer, B., M. Vergelli, L. Tranquill, P. Conlon, N. Ling, H. F. McFarland, and R. Martin. 1997. Human T-cell response to myelin basic protein peptide (83-99): extensive heterogeneity in antigen recognition, function, and phenotype. Neurology 49:1116.
14. Hinrichs, D. J., K. W. Wegmanm, and G. N. Dietsch. 1987. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras: endothelial cells are not a restricting element. J. Exp. Med. 166:1906.
15. Hickey, W. F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290.
16. Subramanian, S., D. N. Bourdette, C. Corless, A. A. Vandenbark, H. Offner, and R. E. Jones. 2001. T lymphocytes promote the development of bone marrow-derived APC in the central nervous system. J. Immunol. 166:370.
17. Zajicek, J., and A. Compston. 1995. Mechanisms of damage and repair in multiple sclerosis-a review. Mult. Scler. 1:61.
18. Lassmann, H. 1997. Basic mechanisms of brain inflammation. J. Neural Transm. Suppl. 50:183.
19. Vanderlugt, C. L., W. S. Begolka, K. L. Neville, Y. Katz-Levy, L. M. Howard, T. N. Eagar, J. A. Bluestone, and S. D. Miller. 1998. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164:63.
20. Werdelin, O., and R. T. McCluskey. 1971. The nature and the specificity of mononuclear cells in experimental autoimmune inflammations and the mechanisms leading to their accumulation. J. Exp. Med. 133:1242.
21. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest 63:162.
22. Kawai, K., K. Ito, K. Imamura, W. F. Hickey, B. Zweiman, and A. Takahashi. 1993. Enhancing effects of irrelevant lymphocytes on adoptive transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 42:39.
23. Cross, A. H., B. Cannella, C. F. Brosnan, and C. S. Raine. 1991. Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J. Neuroimmunol. 33:237.
24. Ben-Nun, A., S. Yossefi, and D. Lehmann. 1993. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Eur. J. Immunol 23:689.
25. Robbinson, D., S. Cockle, B. Singh, and G. H. Strejan. 1996. Native, but not genetically inactivated, pertussis toxin protects mice against experimental allergic encephalomyelitis. Cell. Immunol. 168:165.
26. Vandenbark, A. A., B. Celnik, M. Vainiene, S. D. Miller, and H. Offner. 1995. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J. Immunol. 155:5861.
27. Jewell, S. D., I. E. Gienapp, K. L. Cox, and C. C. Whitacre. 1998. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy. Immunol. Cell Biol. 76:74.
28. Moriabadi, N. F., S. Niewiesk, N. Kruse, S. Jung, B. Weissbrich, V. ter Meulen, K. V. Toyka, and P. Rieckmann. 2001. Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology 56:938.
29. Wingerchuk, D. M., C, F. Lucchinetti, and J. H. Noseworthy. 2001. Multiple sclerosis: current pathophysiological concepts. Lab. Invest. 81:263.
30. Oksenberg, J. R., S. E. Baranzini, L. F. Barcellos, and S. L. Hauser. 2001. Multiple sclerosis: genomic rewards. J. Neuroimmunol. 113:171.
31. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.